图像和基于临床的STN-DBS编程之间的一致性改善了帕金森病中定向刺激的运动结果
Leonardo Rigon1,2, Francesco Bove1,3, Alessandro Izzo4
1Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy.
Journal of Parkinson's disease
|March 17, 2025
概括
影像软件准确地预测了帕金森病 (PD) 患者进行深度脑刺激 (DBS) 的刺激接触水平. 一致的定向编程改善了运动结果,突出显示了软件在DBS治疗中的价值.
科学领域:
- 神经外科 神经外科
- 神经学 神经学
- 医疗成像医学成像
背景情况:
- 在亚thalamic核深度大脑刺激 (STN-DBS) 方向刺激增强帕金森病 (PD) 治疗,但复杂的编程.
- 局部化软件为选择最佳刺激接触者提供了潜在的帮助.
研究的目的:
- 评估成像建议编程 (IGP) 和常规编程 (CP) 之间的协议,用于STN-DBS接触者手术后一年.
- 评估本协议对PD患者运动结果的影响.
主要方法:
- 分析了64名双边STN-DBS的PD患者.
- 使用BrainlabTM软件进行了位定位,以预测最佳接触水平和方向性.
- 预测和临床激活接触者之间的一致性被计算出来,并与运动症状严重程度相关联 (UPDRS-III).
主要成果:
- 对于活跃刺激的垂直接触水平,观察到80%的一致性,对于IGP和CP之间的方向性,51%的一致性.
- 根据接触水平一致性,没有发现显著的运动结果差异.
- 与不一致的患者相比,接受一致的IGP/CP定向刺激的患者显示出明显更好的运动改善 (UPDRS-III).
结论:
- 基于成像的重建软件准确预测有效的STN-DBS接触水平,简化了编程.
- 通过成像指导的定向刺激编程的一致性与PD患者的优异运动结果有关.
- 可视化软件提供了附加值,特别是在优化定向STN-DBS编程方面.
相关概念视频
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Parkinson's Disease: Treatment
174
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
174
Parkinson's Disease: Overview
410
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
410


